Table 1. Demographic characteristics of evaluable patients according to the study and randomized arm they were allocated to.
| Characteristic | Part A | Part B | ||
|---|---|---|---|---|
| Monitor | Treat | 2 <200 | 2 <3000 | |
| Number of patients | 32 | 27 | 55 | 51 |
| Transplant | ||||
| • Kidney | 12 | 13 | 28 | 27 |
| • Liver | 12 | 8 | 16 | 14 |
| • Bone marrow | 8 | 6 | 11 | 10 |
| High CMV risk | ||||
| • D+ R- SOT | 3 | 2 | 16 | 17 |
| • D- R+ BMT | 2 | 2 | 3 | 3 |
| Male | 23 | 21 | 37 | 24 |
| Female | 9 | 6 | 18 | 27 |
| Age | ||||
| • Median | 49 | 52 | 50 | 51.5 |
| • Range | 19–76 | 17–74 | 17–67 | 22–71 |
| Race | ||||
| • Caucasian | 17 | 13 | 34 | 32 |
| • Black | 3 | 4 | 10 | 5 |
| • Asian | 11 | 8 | 7 | 8 |
| • Hispanic | 0 | 0 | 0 | 0 |
| • Other | 1 | 2 | 5 | 5 |